NEO vs. NB
NEO (NeoGenomics, Inc.) and NB (NioCorp Developments Ltd. Common Stock) are both stocks. NEO operates in Diagnostics & Research (Healthcare), while NB operates in Other Industrial Metals & Mining (Basic Materials). Over the past 3 years, NEO returned -8.19%/yr vs -2.92%/yr for NB. At a 0.09 correlation, their price movements are largely independent.
Performance
NEO vs. NB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NEO achieves a 9.69% return, which is significantly higher than NB's -12.83% return.
NEO
- 1D
- 12.47%
- 1M
- 39.76%
- YTD
- 9.69%
- 6M
- 4.88%
- 1Y
- 78.42%
- 3Y*
- -8.19%
- 5Y*
- -22.59%
- 10Y*
- 4.89%
NB
- 1D
- -5.91%
- 1M
- -14.44%
- YTD
- -12.83%
- 6M
- -24.26%
- 1Y
- 75.00%
- 3Y*
- -2.92%
- 5Y*
- —
- 10Y*
- —
NEO vs. NB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
NEO NeoGenomics, Inc. | 9.69% | -28.64% | 1.85% | -12.40% |
NB NioCorp Developments Ltd. Common Stock | -12.83% | 241.94% | -51.41% | -57.47% |
Correlation
The correlation between NEO and NB is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 21, 2023 | 0.09 |
Fundamentals
NEO:
$333.25M
NB:
$629.02M
NEO:
-$3.86
NB:
-$0.52
NEO:
0.40
NB:
1.44
NEO:
$745.97M
NB:
$0.00
NEO:
$314.28M
NB:
-$1.00K
NEO:
-$50.56M
NB:
-$54.65M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NEO vs. NB — Risk / Return Rank
NEO
NB
NEO vs. NB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NeoGenomics, Inc. (NEO) and NioCorp Developments Ltd. Common Stock (NB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NEO | NB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.60 | ||
| Sortino ratioReturn per unit of downside risk | +0.39 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.19 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.73 | 1.18 | +0.55 |
| Martin ratioReturn relative to average drawdown | 3.78 | 1.78 | +2.00 |
Loading charts...
Drawdowns
NEO vs. NB - Drawdown Comparison
The maximum NEO drawdown since its inception was -91.92%, which is greater than NB's maximum drawdown of -82.83%. Use the drawdown chart below to compare losses from any high point for NEO and NB.
Loading charts...
Drawdown Indicators
| NEO | NB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.92% | -82.83% | -9.09% |
Max Drawdown (1Y)Largest decline over 1 year | -45.61% | -64.10% | +18.49% |
Max Drawdown (3Y)Largest decline over 3 years | -76.65% | -75.00% | -1.65% |
Max Drawdown (5Y)Largest decline over 5 years | -90.78% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -91.92% | — | — |
Current DrawdownCurrent decline from peak | -78.46% | -60.41% | -18.05% |
Average DrawdownAverage peak-to-trough decline | -36.98% | -55.96% | +18.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.83% | 42.23% | -21.40% |
Volatility
NEO vs. NB - Volatility Comparison
The current volatility for NeoGenomics, Inc. (NEO) is 20.67%, while NioCorp Developments Ltd. Common Stock (NB) has a volatility of 25.43%. This indicates that NEO experiences smaller price fluctuations and is considered to be less risky than NB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NEO | NB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.67% | 25.43% | -4.76% |
Volatility (6M)Calculated over the trailing 6-month period | 38.53% | 65.88% | -27.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.83% | 108.65% | -47.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.59% | 91.59% | -22.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.20% | 91.59% | -33.39% |
Dividends
NEO vs. NB - Dividend Comparison
Neither NEO nor NB has paid dividends to shareholders.
Financials
NEO vs. NB - Financials Comparison
This section allows you to compare key financial metrics between NeoGenomics, Inc. and NioCorp Developments Ltd. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NEO and NB have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NB has higher volatility (25.43%) compared to NEO (20.67%). In terms of maximum drawdown, NEO dropped -91.92% vs NB's -82.83%.
NEO currently has the higher Sharpe Ratio (1.30 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NEO and NB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer